AstraZeneca (AZN) to Join Nasdaq-100 Index

(Updated - February 10, 2022 5:02 PM EST)

Nasdaq today announced that AstraZeneca PLC – ADR (Nasdaq: AZN), will become a component of the NASDAQ-100 Index® and the NASDAQ-100 Equal Weighted Index prior to market open on Tuesday, February 22, 2022. AstraZeneca PLC – ADR will replace Xilinx, Inc. in the NASDAQ-100 Index® and the NASDAQ-100 Equal Weighted Index.

For more information about the company, go to https://www.astrazeneca.com.

You May Also Be Interested In

• Tesla (TSLA) Delivered 486,532 Vehicles in Q3 vs Consensus of 461,974
• Ford Motor Q3 vehicle sales fall 6.6%, F-Series leads gains
• NeuroSense faces Nasdaq delisting risk over market value rule